Top News Stories
Cost-Containment
Capital Blue Cross partners with Cost Plus Drugs to slash specialty Rx costs
By Alan GoforthCapital Blue Cross is partnering with the Mark Cuban Cost Plus Drug Co. to make lower‑cost biosimilar alternatives to Humira and Stelara available to commercial members.






